ZLAB:NASDAQ, Zai Lab Limited

ZLAB stock overview

Zai Lab Limited (ZLAB:NASDAQ) closed at $21.03 on November 20, 2026, down 4.06% on the day. The stock trades 27.5% below its 52-week high of $29.02 and 31.8% above its 52-week low of $15.96. Over the past year, it gained 5.0%. Zai Lab Limited is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$21.03
Day change
-4.06%
Volume
1,442,215
Average volume
984,451
Market cap
2B+
52-week range
$15.96 – $29.02
50-day average
$24.42
200-day average
$21.42

Price action over the past year

In 252 trading sessions since November 20, 2025, ZLAB closed higher on 111 days (44%). Its best day was August 6, 2026 (+13.66%) and its worst was October 22, 2026 (-8.93%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

ZLAB news

About Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases.

Similar stocks

Find more stocks like ZLAB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.